All News about Roivant Sciences Ltd
Assessing Roivant Sciences: Insights From 5 Financial Analysts
January 02, 2024
Via Benzinga
Analyst Ratings for Roivant Sciences
December 12, 2023
Via Benzinga
8 Analysts Have This to Say About Roivant Sciences
November 14, 2023
Via Benzinga
Roivant Sciences Earnings Preview
February 12, 2024
Via Benzinga
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
Roivant Sciences Earnings Preview
November 10, 2023
Via Benzinga
From Roivant Sciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.